ArticleSurgical endoscopy2026
Association of perioperative patient characteristics, intraoperative fluid management, and vasopressors with anastomotic leakage after Ivor-Lewis esophagectomy-a single center retrospective cohort.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnastomotic leak (AL) is a significant complication after esophagectomy, occurring in 9-11% of cases, increasing morbidity and resource utilization. This study evaluated perioperative, surgical, and hemodynamic factors associated with AL after Ivor Lewis esophagectomy.
methodsWe conducted a retrospective study of patients who underwent Ivor Lewis esophagectomy for esophageal cancer between January 2018 and September 2024. Demographic, comorbidity, operative, vasopressor, and fluid management data were collected. Univariate analyses used Fisher's exact and Mann-Whitney U tests. Variables with p < 0.1 and clinically relevant covariates were included in stepwise multivariable logistic regression.
resultsAmong 208 patients, 16 (7.7%) developed AL. Baseline demographics and neoadjuvant therapy did not differ between groups. In multivariable analysis, preoperative P2Y12 inhibitor therapy (OR 9.3, 95% CI 2.4-36.3, p < 0.001) and intraoperative vasopressin administration (OR 4.0, 95% CI 1.3-12.0, p = 0.014) were independently associated with AL. Phenylephrine monotherapy had the lowest AL rate (3.6%), whereas the addition of vasopressin increased risk nearly fivefold (18%). Peripheral vascular disease was significant in univariate analysis but not retained in multivariable modeling. AL was associated with a prolonged hospital stay (median 18.5 vs 9 days, p < 0.001), higher 30-day readmission (25% vs 3.6%, p = 0.006), and increased reintubation (31.3% vs 12.0%, p = 0.046), but not with higher 30- or 90-day mortality.
conclusionsPreoperative P2Y12 therapy and intraoperative vasopressin use were independently associated with AL after esophagectomy. P2Y12 therapy may reflect high-risk vascular biology, while vasopressor selection represents a modifiable factor. These findings warrant validation but support the careful selection of vasopressors and enhanced monitoring in P2Y12 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.